Medical Sciences Division Industry Insights Seminar Series – Target discovery opportunities using machine learning on longitudinal patient journeys

7th December 2021 @ 12:00 pm - 1:30 pm
Loading Events

« All Events

  • This event has passed.

Target discovery opportunities using machine learning on longitudinal patient journeys.

Presenter: Ramneek Gupta-Head of Computational Biology

For almost 100 years, Novo Nordisk have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, eg insulin pens. Their treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases. From their labs they are discovering and developing innovative biological medicines and making them accessible to patients throughout the world.

Details

Date:
7th December 2021
Time:
12:00 pm - 1:30 pm
Event Categories:
,
Website:
Book now

Venue

Online

Latest news

Nick Greenhalgh, co-founder and CEO of Luca

Nick Greenhalgh, co-founder and CEO of Luca

For almost 100 years, Novo Nordisk have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, eg insulin pens. Their treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases. From their labs they are discovering and developing innovative biological medicines and making them accessible to patients throughout the world. Learn more

Joe Brown, co-founder of URSOR

Joe Brown, co-founder of URSOR

For almost 100 years, Novo Nordisk have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, eg insulin pens. Their treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases. From their labs they are discovering and developing innovative biological medicines and making them accessible to patients throughout the world. Learn more

Nick Henry, founder of Nick Henry Consulting Ltd

Nick Henry, founder of Nick Henry Consulting Ltd

For almost 100 years, Novo Nordisk have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, eg insulin pens. Their treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases. From their labs they are discovering and developing innovative biological medicines and making them accessible to patients throughout the world. Learn more

Asha Vettoor, Founder of SwaraVOW

Asha Vettoor, Founder of SwaraVOW

For almost 100 years, Novo Nordisk have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, eg insulin pens. Their treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases. From their labs they are discovering and developing innovative biological medicines and making them accessible to patients throughout the world. Learn more

Enterprising Oxford

Tell us a bit about yourself and see information and resources relevant to your needs.

Get in touch

3 + 1 =

Copyright © 2022 Enterprising Oxford | Site by Herd